Status and phase
Conditions
Treatments
About
The study is being conducted to evaluate the tolerability, safety and efficacy of maintenance Fluzoparib monotherapy in patients with gBRCA/PALB2 mutated metastatic pancreatic cancer whose disease has not progressed on first line platinum based chemotherapy.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Key Inclusion Criteria:
Major Exclusion Criteria:
Primary purpose
Allocation
Interventional model
Masking
5 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Chunlei Jin, Ph.D
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal